top of page
PASSRACGP Logo_white.png

Progress

0%

Cardiovascular

Erythema Multiforme



Definition

  • Self-limiting, immune-mediated condition affecting mucocutaneous surfaces. Presents with target-like lesions and can be isolated, recurrent, or persistent.

  • Primarily affects young adults (~1%).



Aetiology & Causes

  • Idiopathic (common)

  • Infections:

    • Herpes simplex virus (HSV) (most common)

    • Mycoplasma pneumoniae (next most common), COVID-19, CMV, EBV

  • Drugs: Sulphonamides (e.g. co-trimoxazole), penicillins, anticonvulsants

  • Systemic disease: SLE, Hodgkin’s lymphoma

  • Vaccinations


Clinical Features


Skin Lesions

  • Symmetrical rash, mainly on extensor surfaces

  • Target lesions (hallmark sign) with three zones:

    • Dusky centre (epidermal necrosis)

    • Pale oedematous ring

    • Peripheral erythematous rim

  • May be painful, itchy, or swollen


Mucosal Involvement

  • Blisters → shallow ulcers covered by a white membrane

  • Affects oral mucosa, causing pain with eating/swallowing


Diagnosis

  • Clinical diagnosis based on history and examination

  • If doubt: Consider keratitis, conjunctival screening, uveitis (risk of visual impairment)


Differential Diagnosis

  • SJS/TEN (key distinction):

    • More severe mucosal damage, skin peeling, systemic illness

  • Others:

    • Urticaria, viral exanthem, fixed drug eruption

    • Bullous pemphigoid, paraneoplastic pemphigus

    • Polymorphous light eruption, Rowell syndrome (SLE-related)


Management

  • Usually self-limiting, no specific treatment needed

  • Symptomatic care:

    • Itching: Antihistamines, topical steroids, cool compresses

    • Pain: Local anaesthetic gels, mouth rinses

    • Eye involvement: Urgent ophthalmology referral

  • Recurrent/severe cases:

    • Oral antivirals (e.g. aciclovir) if HSV-related

    • Antibiotics if bacterial trigger (e.g. Mycoplasma pneumoniae)


Prognosis

  • Minor cases resolve in 2–3 weeks without scarring

  • Erythema multiforme major may take up to 6 weeks

  • Rare progression to SJS/TEN, but eye involvement may cause long-term complications (e.g. vision loss)

Bookmark Failed!

Bookmark Saved!

bottom of page